文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

YAP 和 TEAD 复合物的结构见解。

Structural insights into the YAP and TEAD complex.

机构信息

School of Life Sciences, Fudan University, Shanghai 200433, China.

出版信息

Genes Dev. 2010 Feb 1;24(3):235-40. doi: 10.1101/gad.1865810.


DOI:10.1101/gad.1865810
PMID:20123905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2811825/
Abstract

The Yes-associated protein (YAP) transcriptional coactivator is a key regulator of organ size and a candidate human oncogene inhibited by the Hippo tumor suppressor pathway. The TEAD family of transcription factors binds directly to and mediates YAP-induced gene expression. Here we report the three-dimensional structure of the YAP (residues 50-171)-TEAD1 (residues 194-411) complex, in which YAP wraps around the globular structure of TEAD1 and forms extensive interactions via three highly conserved interfaces. Interface 3, including YAP residues 86-100, is most critical for complex formation. Our study reveals the biochemical nature of the YAP-TEAD interaction, and provides a basis for pharmacological intervention of YAP-TEAD hyperactivation in human diseases.

摘要

Yes 相关蛋白 (YAP) 转录共激活因子是器官大小的关键调节因子,也是 Hippo 肿瘤抑制途径抑制的候选人类癌基因。TEAD 家族转录因子直接结合并介导 YAP 诱导的基因表达。在这里,我们报告了 YAP(残基 50-171)-TEAD1(残基 194-411)复合物的三维结构,其中 YAP 包裹在 TEAD1 的球状结构周围,并通过三个高度保守的界面形成广泛的相互作用。界面 3,包括 YAP 残基 86-100,对复合物形成最为关键。我们的研究揭示了 YAP-TEAD 相互作用的生化性质,并为在人类疾病中对 YAP-TEAD 过度激活进行药理学干预提供了基础。

相似文献

[1]
Structural insights into the YAP and TEAD complex.

Genes Dev. 2010-2-1

[2]
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.

Protein Sci. 2017-12

[3]
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.

J Med Chem. 2015-6-25

[4]
Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.

Sci Rep. 2017-5-17

[5]
Structural basis of YAP recognition by TEAD4 in the hippo pathway.

Genes Dev. 2010-2-1

[6]
Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.

FASEB J. 2014-11-10

[7]
TEAD mediates YAP-dependent gene induction and growth control.

Genes Dev. 2008-7-15

[8]
The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.

Biochem Biophys Res Commun. 2013-12-28

[9]
Allosteric Modulation of the YAP/TAZ-TEAD Interaction by Palmitoylation and Small-Molecule Inhibitors.

J Phys Chem B. 2024-4-25

[10]
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.

Biochem J. 2018-6-26

引用本文的文献

[1]
XMU-MP-1, Inhibitor of STE20-like MST1/2 Kinases of the Hippo Signaling Pathway, Suppresses the Cell Cycle, Activates Apoptosis and Autophagy, and Induces Death of Hematopoietic Tumor Cells.

Pharmaceuticals (Basel). 2025-6-12

[2]
Emerging mechanomedicines informed by mechanotransduction along the integrin-cytoskeleton-nucleus axis.

APL Bioeng. 2025-6-10

[3]
Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways.

Naunyn Schmiedebergs Arch Pharmacol. 2025-5-29

[4]
Hand Osteoarthritis: Molecular Mechanisms, Randomized Controlled Trials, and the Future of Targeted Treatment.

Int J Mol Sci. 2025-5-9

[5]
Interpreting regulatory mechanisms of Hippo signaling through a deep learning sequence model.

Cell Genom. 2025-4-9

[6]
Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer.

Am J Cancer Res. 2025-1-15

[7]
The YAP1-MAML2 fusion drives tumorigenesis and sustains tumor growth.

Mol Ther Oncol. 2024-10-28

[8]
Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities.

Acta Pharm Sin B. 2024-10

[9]
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.

Mol Divers. 2025-6

[10]
TLK1>Nek1 Axis Promotes Nuclear Retention and Activation of YAP with Implications for Castration-Resistant Prostate Cancer.

Cancers (Basel). 2024-8-22

本文引用的文献

[1]
Structural basis of YAP recognition by TEAD4 in the hippo pathway.

Genes Dev. 2010-2-1

[2]
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.

J Biol Chem. 2009-5-15

[3]
TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.

J Biol Chem. 2009-5-22

[4]
The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass.

Dev Cell. 2009-3

[5]
Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.

Cancer Res. 2009-2-1

[6]
YAP regulates neural progenitor cell number via the TEA domain transcription factor.

Genes Dev. 2008-12-1

[7]
Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.

Development. 2008-12

[8]
Searching protein structure databases with DaliLite v.3.

Bioinformatics. 2008-12-1

[9]
Expression of Yes-associated protein in common solid tumors.

Hum Pathol. 2008-11

[10]
TEAD mediates YAP-dependent gene induction and growth control.

Genes Dev. 2008-7-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索